Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Third Rock Ventures LLC

*Key People: Third Rock

Parents

Cary Pfeffer, M.D., interim chief executive officer of Faze and partner at Third Rock Ventures (2020)
Chris Varma, an entrepreneur-in-residence at Third Rock Ventures, will serve as the company’s first CEO.
David Armistead, who holds the same position at Third Rock, will take on the the role of Chief Scientific Officer.
Lou Tartaglia, a partner at Third Rock, was named to Rhythm Pharmaceuticals’ board
Mark Levin, the founder of Third Rock Ventures, will serve on the company’s board.
Third Rock partners and co-founders Mark Levin, Kevin Starr, and Robert Tepper—a trio who previously held the CEO, COO, and R&D president titles, respectively, at Millennium Pharmaceuticals—bring a lot of experience in building companies.